Schwanzer-Pfeiffer D et al. reported that the low KIAA0247 level induced a downexpression of CCL2 in response to lipopolysaccharides treatment in vitro [38] and upregulation of CCL2 promotes glioma growth [39]. This evidence concerns the gene CCL2 and central nervous system cancer.